首页> 外文期刊>Human mutation >Studies of the variability of the hepatocyte nuclear factor-1beta (HNF-1beta / TCF2) and the dimerization cofactor of HNF-1 (DcoH / PCBD) genes in relation to type 2 diabetes mellitus and beta-cell function.
【24h】

Studies of the variability of the hepatocyte nuclear factor-1beta (HNF-1beta / TCF2) and the dimerization cofactor of HNF-1 (DcoH / PCBD) genes in relation to type 2 diabetes mellitus and beta-cell function.

机译:研究肝细胞核因子-1β(HNF-1beta / TCF2)和HNF-1(DcoH / PCBD)基因的二聚化辅因子与2型糖尿病和β细胞功能有关的变异性。

获取原文
获取原文并翻译 | 示例
       

摘要

Mutations in the homeodomain-containing transcription factor hepatocyte nuclear factor-1beta (HNF-1beta) are known to cause a rare subtype of maturity-onset diabetes of the young (MODY5), which is associated with early-onset progressive non-diabetic renal dysfunction. To investigate whether mutations in HNF-1 are implicated in the pathogenesis of MODY or late-onset diabetes with and without nephropathy in Danish Caucasians we examined the HNF-1beta (TCF2) and the dimerization cofactor of HNF-1 (DCoH, PCBD) genes for mutations in 11 MODY probands, 28 type 2 diabetic patients with nephropathy, and 46 type 2 diabetic patients with an impaired beta-cell function by combined single-strand conformation polymorphism (SSCP) and heteroduplex analysis. Analysis of the promoter and nine exons including intron-exon boundaries of the HNF-1beta gene revealed one novel silent polymorphism and three previously reported intronic variants. The silent polymorphism (I91I) was found in one patient with late-onset type 2 diabetes. One of the intronic variant (IVS6+26T-->C) was examined further. Among 584 type 2 diabetic patients the allelic frequency was 13.1% (11.2-15.0%) compared to 11.6% (8.6-14.5%) in 229 glucose tolerant control subjects (NS). No difference in insulin secretion during an OGTT was seen between carriers of the different IVS6+26T-->C genotypes among the 229 middle-aged control subjects, nor among 302 glucose tolerant 60-year-old Danish Caucasians. Mutation analysis of the four exons comprising the DCoH gene revealed a previously described A-->G polymorphism located in the 3' untranslated region, which was not investigated further. In conclusion, mutations in HNF-1beta and DCoH are not a major cause of MODY or late onset type 2 diabetes in Danish Caucasian subjects. Copyright 2001 Wiley-Liss, Inc.
机译:已知含有同源结构域的转录因子肝细胞核因子1beta(HNF-1beta)中的突变会导致罕见的年轻人成熟型糖尿病(MODY5)亚型,与早期发作的进行性非糖尿病肾功能不全相关。为了研究丹麦高加索人中是否存在HDY-1突变与MODY或迟发性糖尿病伴或不伴肾病的发病机理,我们检查了HNF-1beta(TCF2)和HNF-1的二聚化辅因子(DCoH,PCBD)基因结合单链构象多态性(SSCP)和异源双链分析,对11位MODY先证者,28位2型糖尿病肾病患者和46位β细胞功能受损的2型糖尿病患者进行了突变分析。分析启动子和9个外显子,包括HNF-1beta基因的内含子-外显子边界,揭示了一种新颖的沉默多态性和三个以前报道的内含子变异体。在一名迟发的2型糖尿病患者中发现了沉默多态性(I91I)。进一步研究了一种内含子变体(IVS6 + 26T-> C)。在584名2型糖尿病患者中,等位基因频率为13.1%(11.2-15.0%),而229名耐糖性对照受试者(NS)为11.6%(8.6-14.5%)。在229名中年对照受试者以及302名耐糖耐量的60岁丹麦高加索人中,在不同IVS6 + 26T-> C基因型的携带者之间,OGTT期间的胰岛素分泌没有差异。对包含DCoH基因的四个外显子的突变分析显示,先前描述的A→G多态性位于3'非翻译区,对此不做进一步研究。总之,在丹麦高加索受试者中,HNF-1beta和DCoH的突变不是MODY或2型糖尿病晚期发作的主要原因。版权所有2001 Wiley-Liss,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号